Atypical antipsyshotic drugs in treatment-refractory schizophrenia

被引：11
作者：
Bradford, DW
Chakos, MH
Sheitman, BB
Lieberman, JA
机构：
[1] Univ N Carolina, Sch Med, Dept Psychiat, Neurosci Hosp 7025, Chapel Hill, NC 27599 USA
[2] Zeneca Inc, Wilmington, DE USA
[3] Pfizer Inc, New York, NY 10017 USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Pharmacia & Upjohn Inc, Kalamazoo, MI 49001 USA
来源：
PSYCHIATRIC ANNALS | 1998年 / 28卷 / 11期
关键词：
D O I：
10.3928/0048-5713-19981101-06
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
There is great interest in determining whether the atypical antipsychotic drugs have enhanced efficacy in patients with treatment-refractory illness. This article reviews several studies on this topic.
引用
收藏
页码：618 / +
页数：10
相关论文
共 57 条
[1]   The effects of clozapine on symptom clusters in treatment-refractory patients [J].
Abraham, G ;
Nair, C ;
Tracy, JI ;
Simpson, GM ;
Josiassen, RC .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (01) :49-53
[2]   Ten years' experience with clozapine in treatment-resistant schizophrenic patients:: factors indicating the therapeutic response [J].
Alvarez, E ;
Barón, F ;
Perez-Blanco, J ;
Soriano, DPJ ;
Masip, C ;
Perez-Solá, V .
EUROPEAN PSYCHIATRY, 1997, 12 :343S-346S
[3]  
Andreasen N, 1984, SCALE ASSESSMENT POS
[4]  
[Anonymous], 1984, SCALE ASSESSMENT POS
[5]  
Beck NC, 1997, J AM ACAD PSYCHIATRY, V25, P461
[6]   Risperidone versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind study [J].
Bondolfi, G ;
Dufour, H ;
Patris, M ;
May, JP ;
Billeter, U ;
Eap, CB ;
Baumann, P .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (04) :499-504
[7]   DEFINING TREATMENT REFRACTORINESS IN SCHIZOPHRENIA [J].
BRENNER, HD ;
DENCKER, SJ ;
GOLDSTEIN, MJ ;
HUBBARD, JW ;
KEEGAN, DL ;
KRUGER, G ;
KULHANEK, F ;
LIBERMAN, RP ;
MALM, U ;
MIDHA, KK .
SCHIZOPHRENIA BULLETIN, 1990, 16 (04) :551-561
[8]   Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: A within-subject comparison with haloperidol [J].
Brown, AS ;
Gewirtz, G ;
HarkavyFriedman, J ;
Cooper, T ;
Brebion, G ;
AMador, XF ;
Malaspina, D ;
Gorman, JM .
NEUROPSYCHOPHARMACOLOGY, 1997, 17 (05) :317-325
[9]  
Buchanan RW, 1998, AM J PSYCHIAT, V155, P751
[10]  
BUNNEY WE, 1963, ARCH GEN PSYCHIAT, V9, P280
123456